December, 8th, 2023 - Nanjing, China - Vazyme is excited to announce that it has been selected as the 2023 Bioz Stars Award Winner in the Cloning category. We, as always, delicate to serve global researchers for the further progress in science together with other winners TaKaRa, New England Biolabs and OriGene.
Bioz Stars Award recognizes the world's most innovative suppliers of life science reagents, kits, instruments and tools for being leaders in their specific research category. "The award winners are companies that have competed and won in the ultimate runoff between 50,000 suppliers that have their products listed on Bioz.com. Bioz Stars Award winners are selected based on objective scientific data that is analyzed using advanced patented Bioz AI technology. The AI generates objective product ratings and recommendations based on product usage data from within 35 million peer-reviewed scientific articles, to identify those products that are preferred by over 16 million researchers from around the world. The data that researchers trust the most." - Dr. Karin Lachmi, Chief Scientific Officer, President & Founder of Bioz.
As a professional life science supplier, Vazyme has also won Bioz Stars Award in cloning category three times consecutively in the past years, which underscored our unwavering commitment to advancing molecular biology research.
Vazyme provides Molecular Biology Reagents in Cloning for global customers and partners. We serve more than 10 thousand of research groups and labs for over 4 Million molecular cloning experiments performed each year and an average of 8 clones per min. In addition to cloning reagent products, we also have multiple product lines to deliver comprehensive solutions that are tailored to the diverse needs of our customers, Nucleic Acid Extraction Reagents, Molecular Biology Reagents, Cell and Protein Research Reagents, NGS Library Preparation Reagents, Reagents for Bio-Medicine, Instruments, and Lab Consumables.
“Our mission as a provider of life science solutions is delivering accuracy, convenience, speed, and cost-effectiveness. We are dedicated to helping our partners improve efficiency, maximize productivity, and accomplish remarkable research achievements.”- Dr. Zhang Lijun, co-founder and vice president of Vazyme.
Honored as winner of Rising Star Award in Cloning category by Bioz, we will continue to fulfill our mission to create value for our customers by pursuing the highest standards in quality of products and services not only in cloning but for more fields of scientific research. Currently, Vazyme established branches and localized teams to serve global customers in over 60 countries and regions. Moving forward, we remain steadfastly committed to enhancing public health, helping humanity overcome major illnesses, and fostering collaborations towards a healthier future.
About the 2023 Bioz Stars Awards:
Bioz Stars Awards recognize companies that manufacture and supply high quality scientific products for life science research. Award recipients are recognized for their contribution to the life science research community. Bioz Stars Awards are given to companies whose life science research products are consistently chosen by researchers for use in scientific experiments that result in successful publication in leading scientific journals. Bioz AI analyses 35 million published scientific articles to select category leaders for a Bioz Stars Award.
Bioz is the world's most advanced AI search engine for life science experimentation, empowering scientists in biopharma and academia to accelerate their research towards new discoveries. Bioz guides scientists to the most-validated and cost-effective products to use in their experiments by providing them with evidence-based product recommendations. These recommendations have been reverse-engineered from real-world experiments, as described in over 500 million pages of scientific text from peer-reviewed articles. The result: Bioz.com, the world's most comprehensive source of life science product recommendations and experimentation guidance, covering over 300 million products, 50,000 suppliers, 16 million images, and over 7 billion protocol conditions and associated techniques, enabling researchers to work faster and more cost-effectively, generating more successful and impactful outcomes.
Vazyme (688105.SH) is a global technology and service provider that specializes in the design, manufacture, and application of bioactive compounds and continuously expands the application fields of core technologies in life sciences, in vitro diagnostics, bio-medicine, and exploratory business. Over the years, we have been advancing and expanding our underlying technology platform through innovation in enzyme and protein technologies, and cultivated end-product development capabilities. Our R&D efforts have allowed us to expand into a wide range of industries, including life sciences, in vitro diagnostics, bio-medicine, and exploratory business. For now we have developed over 300 types of genetically engineered recombinant enzymes and over 1,200 types of high-performance materials and over 1,500 end products. While remaining steadfast to high quality standards, producing all core materials in-house and adhering to GMP quality control standards, we endeavor to maintain a stable and sufficient supply with more than 100000㎡ production facilities.